Trial Profile
PHARMACOKINETICS OFDANAPAROID SODIUM (ORGARAN), FONDAPARINUX SODIUM(ARIXTRA) AND NADROPARIN CALCIUM (FRAXIPARIN) IN PATIENTS AFTER CPB: A PILOT STUDY.
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 02 Apr 2012
Price :
$35
*
At a glance
- Drugs Danaparoid sodium (Primary) ; Fondaparinux sodium (Primary) ; Nadroparin calcium (Primary)
- Indications Thrombosis
- Focus Pharmacodynamics; Pharmacokinetics; Therapeutic Use
- 23 Jul 2011 New trial record